MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$5,447K
EPS
-$0.3
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
2,135
General and administrative
3,437
Total operating expenses
5,572
Loss from operations
-5,572
Interest income
125
Total other income (expenses)
125
Net loss
-5,447
Basic EPS
-0.3
Diluted EPS
-0.3
Basic Average Shares
18,427,787
Diluted Average Shares
18,427,787
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$125K Net loss-$5,447K Total other income(expenses)$125K Loss from operations-$5,572K Total operatingexpenses$5,572K General andadministrative$3,437K Research and development$2,135K

Kairos Pharma, LTD. (KAPA)

Kairos Pharma, LTD. (KAPA)